Malignant Soft Tissue Neoplasm — Trials

Malignant Soft Tissue Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,396 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 341
Recruiting: 190
Ph III recruiting: 14
Growth YoY: −18.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (200)

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04145518	Mechanistic Characterization of Uterine Pain(MCUP)	completed	Phase 4	183	Endeavor HealthOTHER	1	Sep 23, 2026	clinicaltrials
NCT03514381	Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma(IPIAP-STM)	completed	Phase 4	59	Institut Claudius RegaudOTHER	1	Apr 14, 2026	clinicaltrials